# Bivalirudin in Stable Ischemic Heart Disease Patients Undergoing PCI

> **NCT02787317** · PHASE4 · UNKNOWN · sponsor: **Chinese PLA General Hospital** · enrollment: 1770 (estimated)

## Conditions studied

- Coronary Disease

## Interventions

- **DRUG:** bivalirudin
- **DRUG:** Heparin

## Key facts

- **NCT ID:** NCT02787317
- **Lead sponsor:** Chinese PLA General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-05
- **Primary completion:** 2017-10
- **Final completion:** 2018-11
- **Target enrollment:** 1770 (ESTIMATED)
- **Last updated:** 2016-06-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02787317

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02787317, "Bivalirudin in Stable Ischemic Heart Disease Patients Undergoing PCI". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT02787317. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*